Celyad Oncology SA announced that it has entered into a subscription agreement with an affiliate of Fortress Investment Group LLC for private placement of 6,500,000 shares at an issue price of €4.42 per share for gross proceeds of €28,730,000 on December 3, 2021. The transaction is expected to close on or about December 8, 2021, subject to satisfaction of customary closing conditions. Post-closing of transaction, investor will hold 28.8% of the company’s shares. The shares are subject to hold period.